Stay updated on Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3, indicating a new release.
    Difference
    0.2%
    Check dated 2024-09-04T05:23:08.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.2%
    Check dated 2024-08-13T23:34:09.000Z thumbnail image
  5. Check
    32 days ago
    No Change Detected
  6. Check
    47 days ago
    Change Detected
    Summary
    The website has been updated to include new interventions and the addition of the drug Tucatinib, with the revision now at v2.10.0, replacing the previous version v2.9.7.
    Difference
    1%
    Check dated 2024-07-23T14:37:59.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.2%
    Check dated 2024-07-16T06:22:46.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-07-02T13:48:03.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-27T09:51:20.000Z thumbnail image

Stay in the know with updates to Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib in HER2+ Metastatic Breast Cancer Clinical Trial page.